US EditionProfound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost - Profound Medical (NASDAQ:PROF)
Summary by Benzinga
2 Articles
2 Articles
All
Left
Center
1
Right
1
Profound Medical Receives U.S. FDA 510(k) Clearance for TULSA-PRO® Thermal Boost - Profound Medical (NASDAQ:PROF)
TORONTO, Sept. 25, 2023 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF, TSX:PRN) ("Profound" or the "Company"), a commercial-stage medical device company that develops and markets customizable, incision-free therapies for the ablation of diseased tissue, today announced that it has received 510(k) clearance from the U.S. Food and Drug Administration ("FDA) for the Company's Thermal Boost module for use in conjunction with TULSA-PRO®. …
·New York, United States
Read Full ArticleCoverage Details
Total News Sources2
Leaning Left0Leaning Right1Center1Last UpdatedBias Distribution50% Center, 50% Right
Bias Distribution
- 50% of the sources are Center, 50% of the sources lean Right
50% Right
C 50%
R 50%
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
